Vaxcyte(DE:5VA)
€57.50-2.00 (-3.36%)
DE:5VA
Vaxcyte earnings date
€57.50
At close:-2.00 (-3.36%)
Vaxcyte (5VA) Q4 2024 Earnings Report
3 Followers
DE:5VA Q4 2024 EPS Results
- Actual EPS
- -EUR 0.91
- Consensus EPS
- -EUR 0.99
- Beat/Miss
- Beat by +EUR 0.08
- One Year Ago EPS
- -EUR 1.64
DE:5VA Q4 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 02/25/2025
- Time
- After Close
- Conference Call
- Tuesday, February 25, 2025
DE:5VA Upcoming Earnings
Vaxcyte's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q4 2024 Earnings Call Audio
DE:5VA Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:5VA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -1.72- | -1.62 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | -1.89-1.78 | -1.4 | -27.56% (-0.39) | |
| Aug 05, 2026 | 2026 (Q2) | -1.84-1.76 | -1.09 | -61.48% (-0.67) | |
| May 06, 2026 | 2026 (Q1) | -1.59-2.06 | -0.93 | -121.15% (-1.13) | |
| Feb 24, 2026 | 2025 (Q4) | -1.37-1.62 | -0.91 | -77.45% (-0.71) | |
| Nov 04, 2025 | 2025 (Q3) | -1.11-1.40 | -0.74 | -87.95% (-0.65) | |
| Aug 06, 2025 | 2025 (Q2) | -1.04-1.09 | -0.98 | -10.91% (-0.11) | |
| May 07, 2025 | 2025 (Q1) | -0.95-0.93 | -0.76 | -22.35% (-0.17) | |
| Feb 25, 2025 | 2024 (Q4) | -0.99-0.91 | -1.64 | 44.26% (+0.73) | |
| Nov 05, 2024 | 2024 (Q3) | -0.99-0.74 | -0.81 | 8.79% (+0.07) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


